(DOCU) DocuSign - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US2561631068
Stock: E-Signature, IAM Platform, CLM, Real Estate, Notary
Total Rating 24
Risk 46
Buy Signal -0.52
| Risk 5d forecast | |
|---|---|
| Volatility | 45.8% |
| Relative Tail Risk | -10.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.95 |
| Alpha | -65.04 |
| Character TTM | |
|---|---|
| Beta | 1.196 |
| Beta Downside | 0.812 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.98% |
| CAGR/Max DD | -0.18 |
EPS (Earnings per Share)
Revenue
Description: DOCU DocuSign February 28, 2026
DocuSign, Inc. (NASDAQ: DOCU) delivers a cloud-based, AI-enhanced agreement platform that spans e-signatures, contract lifecycle management, document generation, and specialized solutions such as remote notarization and real-estate transaction workflows, serving both commercial customers and U.S. federal agencies.
In its latest fiscal quarter (Q4 FY 2025), DocuSign posted $1.12 billion in revenue, a 13% year-over-year increase, with subscription revenue growing 15% and non-GAAP operating margin expanding to 21%, reflecting strong demand for its Intelligent Agreement Management suite.
The digital-agreement market is being propelled by continued remote-work adoption, heightened regulatory scrutiny on electronic records, and a broader shift toward cloud-native SaaS solutions-trends that have helped the Application Software sector post a 9% annual growth rate in North America.
For a deeper dive into DocuSign’s valuation metrics, you might explore ValueRay’s analyst tools.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 302.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.25 > 0.02 and ΔFCF/TA 1.22 > 1.0 |
| NWC/Revenue: -15.09% < 20% (prev -9.16%; Δ -5.92% < -1%) |
| CFO/TA 0.28 > 3% & CFO 1.10b > Net Income 302.3m |
| Net Debt (-449.9m) to EBITDA (571.4m): -0.79 < 3 |
| Current Ratio: 0.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (210.6m) vs 12m ago 0.91% < -2% |
| Gross Margin: 79.31% > 18% (prev 0.79%; Δ 7852 % > 0.5%) |
| Asset Turnover: 81.50% > 50% (prev 77.26%; Δ 4.24% > 0%) |
| Interest Coverage Ratio: 133.9 > 6 (EBITDA TTM 571.4m / Interest Expense TTM 2.36m) |
Altman Z'' -2.49
| A: -0.12 (Total Current Assets 1.31b - Total Current Liabilities 1.78b) / Total Assets 3.98b |
| B: -0.42 (Retained Earnings -1.67b / Total Assets 3.98b) |
| C: 0.08 (EBIT TTM 316.0m / Avg Total Assets 3.88b) |
| D: -0.84 (Book Value of Equity -1.68b / Total Liabilities 2.00b) |
| Altman-Z'' Score: -2.49 = D |
Beneish M -3.11
| DSRI: 1.07 (Receivables 364.0m/314.1m, Revenue 3.16b/2.91b) |
| GMI: 1.00 (GM 79.31% / 79.08%) |
| AQI: 1.02 (AQ_t 0.55 / AQ_t-1 0.54) |
| SGI: 1.08 (Revenue 3.16b / 2.91b) |
| TATA: -0.20 (NI 302.3m - CFO 1.10b) / TA 3.98b) |
| Beneish M-Score: -3.11 (Cap -4..+1) = AA |
What is the price of DOCU shares?
As of March 05, 2026, the stock is trading at USD 46.22 with a total of 3,403,894 shares traded.
Over the past week, the price has changed by +6.84%, over one month by -1.13%, over three months by -34.99% and over the past year by -43.68%.
Over the past week, the price has changed by +6.84%, over one month by -1.13%, over three months by -34.99% and over the past year by -43.68%.
Is DOCU a buy, sell or hold?
DocuSign has received a consensus analysts rating of 3.30.
Therefor, it is recommend to hold DOCU.
- StrongBuy: 3
- Buy: 3
- Hold: 16
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the DOCU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 78.3 | 69.4% |
| Analysts Target Price | 78.3 | 69.4% |
DOCU Fundamental Data Overview March 03, 2026
P/E Trailing = 31.5175
P/E Forward = 10.7643
P/S = 2.8574
P/B = 4.5552
P/EG = 0.4099
Revenue TTM = 3.16b USD
EBIT TTM = 316.0m USD
EBITDA TTM = 571.4m USD
Long Term Debt = 150.4m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 15.8m USD (from shortTermDebt, last quarter)
Debt = 150.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -449.9m USD (from netDebt column, last quarter)
Enterprise Value = 8.32b USD (9.03b + Debt 150.4m - CCE 856.9m)
Interest Coverage Ratio = 133.9 (Ebit TTM 316.0m / Interest Expense TTM 2.36m)
EV/FCF = 8.42x (Enterprise Value 8.32b / FCF TTM 987.9m)
FCF Yield = 11.87% (FCF TTM 987.9m / Enterprise Value 8.32b)
FCF Margin = 31.27% (FCF TTM 987.9m / Revenue TTM 3.16b)
Net Margin = 9.57% (Net Income TTM 302.3m / Revenue TTM 3.16b)
Gross Margin = 79.31% ((Revenue TTM 3.16b - Cost of Revenue TTM 653.5m) / Revenue TTM)
Gross Margin QoQ = 79.16% (prev 79.33%)
Tobins Q-Ratio = 2.09 (Enterprise Value 8.32b / Total Assets 3.98b)
Interest Expense / Debt = 0.43% (Interest Expense 654.0k / Debt 150.4m)
Taxrate = 12.36% (11.8m / 95.5m)
NOPAT = 277.0m (EBIT 316.0m * (1 - 12.36%))
Current Ratio = 0.73 (Total Current Assets 1.31b / Total Current Liabilities 1.78b)
Debt / Equity = 0.08 (Debt 150.4m / totalStockholderEquity, last quarter 1.98b)
Debt / EBITDA = -0.79 (Net Debt -449.9m / EBITDA 571.4m)
Debt / FCF = -0.46 (Net Debt -449.9m / FCF TTM 987.9m)
Total Stockholder Equity = 2.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.80% (Net Income 302.3m / Total Assets 3.98b)
RoE = 15.14% (Net Income TTM 302.3m / Total Stockholder Equity 2.00b)
RoCE = 14.72% (EBIT 316.0m / Capital Employed (Equity 2.00b + L.T.Debt 150.4m))
RoIC = 13.87% (NOPAT 277.0m / Invested Capital 2.00b)
WACC = 10.16% (E(9.03b)/V(9.18b) * Re(10.32%) + D(150.4m)/V(9.18b) * Rd(0.43%) * (1-Tc(0.12)))
Discount Rate = 10.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.61%
[DCF] Terminal Value 72.67% ; FCFF base≈948.5m ; Y1≈1.07b ; Y5≈1.44b
[DCF] Fair Price = 88.48 (EV 17.27b - Net Debt -449.9m = Equity 17.72b / Shares 200.3m; r=10.16% [WACC]; 5y FCF grow 14.71% → 2.90% )
EPS Correlation: 22.16 | EPS CAGR: -37.72% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.71 | Revenue CAGR: 9.57% | SUE: 2.09 | # QB: 6
EPS next Quarter (2026-04-30): EPS=0.94 | Chg7d=-0.001 | Chg30d=-0.001 | Revisions Net=+3 | Analysts=17
EPS next Year (2027-01-31): EPS=4.12 | Chg7d=+0.005 | Chg30d=+0.001 | Revisions Net=+18 | Growth EPS=+8.8% | Growth Revenue=+6.7%
[Analyst] Revisions Ratio: +0.27 (7 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.1% (Discount Rate 10.3% - Earnings Yield 3.2%)
[Growth] Growth Spread = -0.6% (Analyst 6.5% - Implied 7.1%)
P/E Forward = 10.7643
P/S = 2.8574
P/B = 4.5552
P/EG = 0.4099
Revenue TTM = 3.16b USD
EBIT TTM = 316.0m USD
EBITDA TTM = 571.4m USD
Long Term Debt = 150.4m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 15.8m USD (from shortTermDebt, last quarter)
Debt = 150.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -449.9m USD (from netDebt column, last quarter)
Enterprise Value = 8.32b USD (9.03b + Debt 150.4m - CCE 856.9m)
Interest Coverage Ratio = 133.9 (Ebit TTM 316.0m / Interest Expense TTM 2.36m)
EV/FCF = 8.42x (Enterprise Value 8.32b / FCF TTM 987.9m)
FCF Yield = 11.87% (FCF TTM 987.9m / Enterprise Value 8.32b)
FCF Margin = 31.27% (FCF TTM 987.9m / Revenue TTM 3.16b)
Net Margin = 9.57% (Net Income TTM 302.3m / Revenue TTM 3.16b)
Gross Margin = 79.31% ((Revenue TTM 3.16b - Cost of Revenue TTM 653.5m) / Revenue TTM)
Gross Margin QoQ = 79.16% (prev 79.33%)
Tobins Q-Ratio = 2.09 (Enterprise Value 8.32b / Total Assets 3.98b)
Interest Expense / Debt = 0.43% (Interest Expense 654.0k / Debt 150.4m)
Taxrate = 12.36% (11.8m / 95.5m)
NOPAT = 277.0m (EBIT 316.0m * (1 - 12.36%))
Current Ratio = 0.73 (Total Current Assets 1.31b / Total Current Liabilities 1.78b)
Debt / Equity = 0.08 (Debt 150.4m / totalStockholderEquity, last quarter 1.98b)
Debt / EBITDA = -0.79 (Net Debt -449.9m / EBITDA 571.4m)
Debt / FCF = -0.46 (Net Debt -449.9m / FCF TTM 987.9m)
Total Stockholder Equity = 2.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.80% (Net Income 302.3m / Total Assets 3.98b)
RoE = 15.14% (Net Income TTM 302.3m / Total Stockholder Equity 2.00b)
RoCE = 14.72% (EBIT 316.0m / Capital Employed (Equity 2.00b + L.T.Debt 150.4m))
RoIC = 13.87% (NOPAT 277.0m / Invested Capital 2.00b)
WACC = 10.16% (E(9.03b)/V(9.18b) * Re(10.32%) + D(150.4m)/V(9.18b) * Rd(0.43%) * (1-Tc(0.12)))
Discount Rate = 10.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.61%
[DCF] Terminal Value 72.67% ; FCFF base≈948.5m ; Y1≈1.07b ; Y5≈1.44b
[DCF] Fair Price = 88.48 (EV 17.27b - Net Debt -449.9m = Equity 17.72b / Shares 200.3m; r=10.16% [WACC]; 5y FCF grow 14.71% → 2.90% )
EPS Correlation: 22.16 | EPS CAGR: -37.72% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.71 | Revenue CAGR: 9.57% | SUE: 2.09 | # QB: 6
EPS next Quarter (2026-04-30): EPS=0.94 | Chg7d=-0.001 | Chg30d=-0.001 | Revisions Net=+3 | Analysts=17
EPS next Year (2027-01-31): EPS=4.12 | Chg7d=+0.005 | Chg30d=+0.001 | Revisions Net=+18 | Growth EPS=+8.8% | Growth Revenue=+6.7%
[Analyst] Revisions Ratio: +0.27 (7 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.1% (Discount Rate 10.3% - Earnings Yield 3.2%)
[Growth] Growth Spread = -0.6% (Analyst 6.5% - Implied 7.1%)